Boston, MA, United States of America

Nelly Malenkovich




Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 460(Granted Patents)


Company Filing History:


Years Active: 2005-2010

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Nelly Malenkovich: Innovator in Immunology

Introduction

Nelly Malenkovich is a prominent inventor based in Boston, MA (US), known for her significant contributions to the field of immunology. With a total of 5 patents, her work focuses on advancing therapeutic methods that enhance immune responses.

Latest Patents

One of her latest patents is titled "Methods for upregulating an immune response with agents that inhibit the interaction between PD-L2 and PD-1." This invention provides isolated nucleic acid molecules, designated PD-L2 nucleic acid molecules, which encode novel B7-related molecules that act as ligands for PD-1. The invention also includes antisense nucleic acid molecules, recombinant expression vectors containing PD-L2 nucleic acid molecules, host cells that have been introduced to these expression vectors, and nonhuman transgenic animals with introduced or disrupted PD-L2 genes. Additionally, it offers isolated PD-L2 polypeptides, fusion proteins, antigenic peptides, and anti-PD-L2 antibodies. Furthermore, it provides methods for promoting or inhibiting the interaction between PD-L2 and PD-1, along with diagnostic and treatment methods utilizing the compositions of the invention.

Another significant patent is "B7-4 Antibodies and uses therefor." This invention presents isolated nucleic acid molecules, designated B7-4 nucleic acid molecules, which encode novel B7-4 polypeptides. It also includes antisense nucleic acid molecules, recombinant expression vectors containing B7-4 nucleic acid molecules, host cells that have been introduced to these expression vectors, and nonhuman transgenic animals with introduced or disrupted B7-4 genes. The invention further provides isolated B7-4 proteins, fusion proteins, antigenic peptides, and anti-B7-4 antibodies, along with diagnostic, screening, and therapeutic methods utilizing the compositions of the invention.

Career Highlights

Nelly has worked with esteemed organizations such as Dana-Farber Cancer Institute Inc. and Genetics Institute, Inc. Her innovative research has significantly impacted the field of cancer immunotherapy.

Collaborations

Some of her notable coworkers include Gordon James Freeman and Tatyana Chernova, who have contributed to her research endeavors.

Conclusion

Nelly Malenkovich's work in immunology exemplifies the importance of innovation in developing

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…